United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Clinical research company Science 37 to go public in $1bn deal with LifeSci Science 37, an American clinical research company, has agreed to merge with blank check company LifeSci Acquisition II… bySrinathMay 8, 2021
